Key Takeaways
- Cycle bottom, no quick turn: Management believes the company is at the bottom of the chemical cycle but sees no green shoots yet; the year is expected to be flattish with a few more quarters of muted investment ahead.
- Order intake up ~18-20% H1: Half-yearly order intake grew meaningfully, driven by strong backlogs in non-glass lined businesses like mixing, heavy engineering and Edlon, offsetting stress in glass lined equipment.
- Non-glass lined diversification is working: Mixing, heavy engineering and filtration & drying are opening petrochemical, oil & gas, food & beverage and semiconductor markets, materially reducing dependence on the agrochemical cycle.
- Margins under pressure, cost project underway: Pricing discounts in glass lined have widened 10-15%, but a major EBITDA improvement project in India is expected to pay off next year.
- What to watch next quarter: Whether large opportunities expected to finalize in Q3 actually convert, any sign of agrochemical investment sentiment turning, and the pace of margin recovery in H2.
Cycle Position & Demand Environment
- Bottom of the cycle, but bottom is lasting: Management stated "we probably are at the bottom of the cycle" but added "how long is this bottom going to continue is probably a little bit longer, I don't see the green shoots yet." The company has been in a down cycle for a couple of years and expects a few more quarters before a turning point.
- Agrochemicals remain the weakest spot: Investments have dried up in the agrochemical sector specifically, and many chemical and agrochemical companies are not clear on their own order intake, visibility and guidance. Management anticipates agrochemicals will remain slow for at least a couple more quarters.
- Pharma showing early pickup: In India, the glass lined business has picked up in the pharmaceutical sector in the last couple of months, with some large projects and more talk of new investment. Weight loss drugs are driving ancillary industries, and patent expiries in 2026-2027 are expected to fuel further growth.
- Americas hesitating, Europe mixed: In the Americas, quotations are taking longer to convert to orders as the market hesitates; capacities created post-pandemic are sufficient and inventories are being backfilled. The Italian glass lined business is doing extremely well and ahead of budget, while US and China remain soft.
- Customer behavior shifting toward sophistication: Customers are asking for more sophisticated equipment to reduce batch times and costs, improve quality, and increase capacity. The CDMO business is growing well in India, and peptide manufacturing is becoming huge globally.
Thomas Kehl: "In America, we do see consumption, we see projects coming in, we have quite a few quotations, the time of when a quotation becomes an order has been slowed down a little bit. This means that the market is somewhat hesitating..."
Revenue Mix & Diversification
- Non-glass lined businesses carrying the load: Mixing, heavy engineering, and Edlon have seen significant growth in order intake and are doing quite well. Mixing opens up petrochemical, oil and gas, food and beverage, and other industries not in a down cycle. Most non-glass lined businesses carry more than a year of backlog.
- Industry diversification is structural, not cyclical: Previously 90% of revenue came from glass lined; now the company is in a much wider industry range, which is why management can say the year will be flat despite a big slowdown in glass lined and chemical/pharma.
- Edlon booked out for the year: Edlon, which caters to the semiconductor industry, is fully booked and some capex has been released to increase capacity as the semiconductor space in the US is doing well.
- Filtration & drying gaining traction: Three new products launched in the last two years are getting good traction in India; a vertical conical dryer has been sold to European customers. The US filtration & drying business is now well set with $4-$5 million annual revenue expected and a team built up for sales and operations.
- Ticket size swings with product mix: Glass lined projects are typically ₹5-6 crores, while heavy engineering projects could be ₹60 crores or ₹100 crores, so the product mix and ticket size keep changing materially quarter to quarter.
- Wallet share growing in key accounts: Key account management has been rebooted with multiple touch points, and cross-selling has become important as the company has multiple products going into the same customer. Wallet share in key accounts has definitely grown.
Tarak Patel: "The chemical cycle will turn, it always happened, it's always been cyclical. This is not something that's new. A couple of years, we have already been in a down cycle, we probably expect a few more quarters, but definitely there will be a turning point..."
Margins & Pricing
- Glass lining pricing under pressure: Discount levels in glass lined equipment have increased by about 10-15%, and a little more in some cases. Prices have now stabilized somewhat, but reversing the trend and increasing prices will be difficult because customers have order history and procurement departments that benchmark aggressively.
- Premium still exists but has limits: Being the market leader, GMM Pfaudler is able to get a little bit of premium over competitors, but cannot have a very large price gap. Some customers specify GMM for glass lined due to quality difference, while less sophisticated customers may try cheaper alternatives and realize later the equipment did not perform as well or last as long.
- Cost optimization project underway: A major EBITDA improvement project is ongoing in India, with actions also taken internationally to reduce cost. Management expects this to start helping from a margin perspective, with the big project in India paying off next year.
- H2 margin recovery expected, but modest: Some margin will be made up in Q3 and Q4, but margins are under pressure. Management hopes to be at a similar level as last year, though some amount of margin will still have to be made. It will be a while before returning to 17-18% margins.
- H1 vs H2 comparison note: In the previous financial year, EBITDA dropped sharply from ₹270-₹272 crores in H1 to ₹205 crores in H2; the current half-year is maintaining similar numbers.
Tarak Patel: "It's always tough to increase price once you have already given the discount because, most customers will have history and data available to say, last order was written so why are you asking so."
Strategic Initiatives
- Poland operations beginning: The company is starting Poland operations, with the first order of equipment made for Mavag, the Swiss subsidiary. The FAT was done recently with encouraging results. Poland becomes a strategic option: its cost structure is significantly lower than Western Europe, and young English-speaking engineers and welders are available without the learning curve experienced in India. Some European customers only accept European-made equipment.
- Global mixing strategy being formalized: 26 people from across geographies are defining a three-year plan for go-to-market, projections and investments. A clear idea is expected on growth areas, geographies and industries, and management may include a slide on mixing in the next investor presentation. An international mixing business head was about to be hired.
- Living Labs collaboration with NCL and CPI: GMM Pfaudler is collaborating with India's National Chemical Lab and the UK's Center for Process Improvement, along with leading chemical companies, to set up a lab focusing on ways to decarbonize the industry. GMM is the only equipment provider among participants.
- Gravner winery order: Gravner, an Italian winery, ordered glass lined steel tanks for wine aging; the first batch will be delivered in a couple of weeks and the second batch at the end of the first quarter.
- Filtration & drying product innovation: Strategy to differentiate by focusing on more value-added and sophisticated products is working, with three new products launched in the last two years gaining good traction.
Tarak Patel: "Poland becomes an opportunity we already have India as a low cost sourcing hub. But we also wanted to have something in Europe, because some of the customers in Europe only accept European made equipment."
Backlog & Execution Visibility
- Higher backlog entering H2: The company entered the second half with a higher backlog versus when the year started, and factories are more filled up from an action perspective. November through February should see much more shipments going out.
- Most backlog ships this calendar year: In India, about 90% of the backlog will be shipped out this quarter. Services and spare parts come on top and are not built into the backlog. Some large international systems projects will take longer to execute due to the nature of that business.
- Large opportunities expected in Q3: Management was happy with order intake; one or two orders got pushed out but generally it was in line with expectations. Large opportunities are expected to finalize in Q3.
- Customer mix is inherently lumpy: Top 10 customers change over three years because projects and investments do not continue every year; one customer will invest and then may stop for two years. This makes quarter-to-quarter comparisons less meaningful.
Tarak Patel: "I don't think we can time the cycle perfectly, there will be a bit of lag between when things change and when we will see results, because the first, people that the cycle should turn is our clients, and then they should get back into the mindset of investment."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full year revenue | Flattish year, H2 a bit stronger than H1 | FY25 |
| Chemical cycle recovery | A few more quarters of muted investment before turning point | At least 2-3 quarters |
| Agrochemical recovery | Remains slow; no green shoots yet | At least a couple more quarters |
| EBITDA improvement project payoff | Big project in India should deliver | Next year (FY26) |
| Global mixing strategy plan | Three-year plan with go-to-market, projections and investments | To be discussed in coming weeks; possible investor presentation inclusion |
| Strategic plan review | Numbers built up to 2027 being reviewed; strategy meeting planned | Early next year |
| Glass lining pricing | Hoping to reverse trend and start increasing prices slowly | No specific timeline |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated revenue | ₹805 cr |
| Consolidated EBITDA margin | 11.6% |
| Standalone revenue | ₹208 cr |
| Standalone EBITDA margin | 10.8% |
| Order intake | ₹762 cr |
| Order backlog | ₹1,773 cr |
| Half-yearly order intake growth | 18%-20% improvement YoY |
| Full-year revenue growth guidance | 3%-4%, flattish |
| Full-year EBITDA (FY24) | ₹477 cr, with ₹270-₹272 cr in H1 and ₹205 cr in H2 |
| Mixing revenue share | ~10% of total revenues |
| Glass lined discount levels | 10%-15% higher than normal, a little bit more in some cases |
| US filtration and drying annual revenue | $4-$5 million expected |
| India backlog shipment | ~90% to be shipped out this quarter |
| Glass lined project ticket size | ₹5-6 cr |
| Heavy engineering project ticket size | ₹60 cr to ₹100 cr |
| Inventory provision (consolidated cash flow) | ₹13.7 cr |